SFRSK2 antikoerper, AW226533 antikoerper, AW492537 antikoerper, AW547358 antikoerper, Wbp6 antikoerper, mSRPK2 antikoerper, sfrsk2 antikoerper, srpk2 antikoerper, srpk2-b antikoerper, srpk2b antikoerper, SRSF protein kinase 2 antikoerper, serine/arginine-rich protein specific kinase 2 antikoerper, SRSF protein kinase 2 L homeolog antikoerper, SRPK2 antikoerper, Srpk2 antikoerper, srpk2 antikoerper, srpk2.L antikoerper
Hintergrund
Serine/arginine-rich protein-specific kinase which specifically phosphorylates its substrates at serine residues located in regions rich in arginine/serine dipeptides, known as RS domains and is involved in the phosphorylation of SR splicing factors and the regulation of splicing. Promotes neuronal apoptosis by up-regulating cyclin-D1 (CCND1) expression. This is done by the phosphorylation of SRSF2, leading to the suppression of p53/TP53 phosphorylation thereby relieving the repressive effect of p53/TP53 on cyclin-D1 (CCND1) expression. Phosphorylates ACIN1, and redistributes it from the nuclear speckles to the nucleoplasm, resulting in cyclin A1 but not cyclin A2 up-regulation. Plays an essential role in spliceosomal B complex formation via the phosphorylation of DDX23/PRP28. Can mediate hepatitis B virus (HBV) core protein phosphorylation. Plays a negative role in the regulation of HBV replication through a mechanism not involving the phosphorylation of the core protein but by reducing the packaging efficiency of the pregenomic RNA (pgRNA) without affecting the formation of the viral core particles.